In our study, 34.4% (31/90) of the patients had CRP ≥40 mg/L, suggesting that the impact of CYP2C19 genotype on VRC C trough may not be significant in this cohort.
← all excerpts
Therapeutic drug monitoring of voriconazole and the impact of inflammation on plasma trough concentrations in children.
1
—
—